Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-03 Sale | 2024-04-05 5:44 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 130,000 | $8.93 | $1,160,900 | 4,077,835 (Indirect Direct) | View |
| 2024-03-28 Sale | 2024-04-01 6:40 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 65,000 | $10.1 | $656,500 | 4,232,835 (Indirect Direct) | View |
| 2024-03-06 Sale | 2024-03-08 7:08 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 61,319 | $11.73 | $719,505 | 10,784,331 (Indirect Direct) | View |
| 2024-02-07 Sale | 2024-02-09 5:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 48,272 | $9.2182 | $444,981 | 9,858,536 (Indirect Direct) | View |
| 2024-01-03 Sale | 2024-01-05 8:03 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 55,853 | $9.4994 | $530,567 | 9,916,808 (Indirect Direct) | View |
| 2023-12-06 Sale | 2023-12-08 5:22 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 59,829 | $7.4946 | $448,394 | 9,982,661 (Indirect Direct) | View |
| 2023-11-01 Sale | 2023-11-03 6:14 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 62,177 | $5.1675 | $321,301 | 10,079,403 (Indirect Direct) | View |
| 2023-10-04 Sale | 2023-10-06 6:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 59,794 | $7.2085 | $431,025 | 10,141,580 (Indirect Direct) | View |
| 2023-09-06 Sale | 2023-09-08 5:01 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 58,765 | $8.8053 | $517,442 | 10,211,374 (Indirect Direct) | View |
| 2023-08-02 Sale | 2023-08-04 5:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 65,015 | $13.04 | $847,712 | 10,297,052 (Indirect Direct) | View |
| 2023-07-12 Sale | 2023-07-14 6:52 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 56,818 | $12.54 | $712,242 | 10,372,067 (Indirect Direct) | View |
| 2023-06-07 Sale | 2023-06-09 5:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 56,436 | $9.0511 | $510,808 | 10,438,885 (Indirect Direct) | View |
| 2023-05-03 Sale | 2023-05-05 6:44 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 58,073 | $4.7928 | $278,335 | 30,174,484 (Indirect Direct) | View |
| 2022-01-05 Sale(A) | 2023-04-28 4:32 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 18,500 | $7.3875 | $136,669 | 73,549,979 (Direct) | View |
| 2023-04-05 Sale | 2023-04-07 5:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 53,327 | $6.5953 | $351,710 | 10,584,055 (Indirect Direct) | View |
| 2023-03-08 Sale | 2023-03-10 5:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 110,890 | $8.0521 | $892,894 | 10,650,382 (Indirect Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:07 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $7.9175 | $166,268 | 10,771,272 (Indirect Direct) | View |
| 2023-02-02 Sale | 2023-02-03 5:11 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $9.2172 | $193,561 | 10,793,618 (Indirect Direct) | View |
| 2023-01-05 Sale | 2023-01-06 6:28 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $7.3872 | $155,131 | 9,584,550 (Indirect Direct) | View |
| 2022-12-01 Sale | 2022-12-02 6:17 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,710 | $9.0392 | $358,947 | 9,662,550 (Indirect Direct) | View |
| 2022-11-03 Sale | 2022-11-04 6:39 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,193 | $10.01 | $392,200 | 9,708,011 (Indirect Direct) | View |
| 2022-10-06 Sale | 2022-10-07 7:19 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 38,553 | $11.58 | $446,574 | 9,747,204 (Indirect Direct) | View |
| 2022-09-01 Sale | 2022-09-02 7:24 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,066 | $10.35 | $404,199 | 9,785,757 (Indirect Direct) | View |
| 2022-08-04 Sale | 2022-08-05 7:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,325 | $9.4865 | $373,058 | 9,843,210 (Indirect Direct) | View |
| 2022-07-07 Sale | 2022-07-08 6:36 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,614 | $9.0535 | $358,647 | 9,882,535 (Indirect Direct) | View |
| 2022-06-02 Sale | 2022-06-06 8:54 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 42,190 | $6.1063 | $257,625 | 9,909,513 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-03 Conversion | 2024-04-05 5:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 50,000 | $0 | 4,077,835 (Indirect) | View |
| 2024-04-03 Gift | 2024-04-05 5:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,077,835 (Direct) | View |
| 2024-03-28 Exercise | 2024-04-01 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,232,835 (Indirect) | View |
| 2024-03-28 Conversion | 2024-04-01 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,232,835 (Indirect) | View |
| 2024-03-28 Gift | 2024-04-01 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,232,835 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 7:08 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,924 | $0 | 10,784,331 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,784,331 (Direct) | View |
| 2024-03-06 Conversion | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 35,000 | $0 | 10,784,331 (Direct) | View |
| 2024-03-06 Gift | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,784,331 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 8,674 | $11.4 | 10,784,331 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 7:57 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 11,148 | $12.43 | 1,104,919 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 6:55 pm | N/A 2034-02-09 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 1,011,495 | $0 | 10,866,798 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 6:55 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 3,233 | $10.09 | 10,866,798 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:34 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,858,536 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,858,536 (Direct) | View |
| 2024-02-07 Conversion | 2024-02-09 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,858,536 (Direct) | View |
| 2024-02-07 Gift | 2024-02-09 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,858,536 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-05 8:03 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,916,808 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-05 8:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,916,808 (Direct) | View |
| 2024-01-03 Conversion | 2024-01-05 8:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 35,000 | $0 | 9,916,808 (Direct) | View |
| 2024-01-03 Gift | 2024-01-05 8:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,916,808 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-08 5:22 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,982,661 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-08 5:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,982,661 (Direct) | View |
| 2023-12-06 Conversion | 2023-12-08 5:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,982,661 (Direct) | View |
| 2023-12-06 Gift | 2023-12-08 5:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,982,661 (Direct) | View |
| 2023-11-15 Tax Withholding | 2023-11-17 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 16,913 | $7.18 | 10,052,490 (Direct) | View |
| 2023-11-15 Conversion | 2023-11-17 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,052,490 (Direct) | View |
| 2023-11-15 Gift | 2023-11-17 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,052,490 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 6:14 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,079,403 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 6:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,079,403 (Direct) | View |
| 2023-11-01 Conversion | 2023-11-03 6:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,079,403 (Indirect) | View |
| 2023-10-16 Conversion | 2023-10-18 5:33 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,131,580 (Direct) | View |
| 2023-10-16 Gift | 2023-10-18 5:33 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,131,580 (Direct) | View |
| 2023-10-04 Exercise | 2023-10-06 6:12 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,141,580 (Direct) | View |
| 2023-10-04 Exercise | 2023-10-06 6:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,141,580 (Direct) | View |
| 2023-09-15 Conversion | 2023-09-19 5:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,201,374 (Direct) | View |
| 2023-09-15 Gift | 2023-09-19 5:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,201,374 (Direct) | View |
| 2023-09-06 Exercise | 2023-09-08 5:01 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,211,374 (Direct) | View |
| 2023-09-06 Exercise | 2023-09-08 5:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,211,374 (Direct) | View |
| 2023-09-06 Conversion | 2023-09-08 5:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,211,374 (Indirect) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 16,913 | $9.19 | 873,806 (Direct) | View |
| 2023-08-09 Conversion | 2023-08-11 4:59 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,326,976 (Direct) | View |
| 2023-08-09 Gift | 2023-08-11 4:59 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,326,976 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 5:51 pm | N/A 2032-02-04 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,924 | $0 | 10,297,052 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 5:51 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,297,052 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 5:51 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 8,674 | $11.4 | 10,297,052 (Direct) | View |
| 2023-07-20 Conversion | 2023-07-21 5:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,362,067 (Direct) | View |
| 2023-07-20 Gift | 2023-07-21 5:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,362,067 (Direct) | View |
| 2023-07-12 Exercise | 2023-07-14 6:52 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,372,067 (Direct) | View |
| 2023-07-12 Exercise | 2023-07-14 6:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,372,067 (Direct) | View |
| 2023-07-12 Conversion | 2023-07-14 6:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,372,067 (Indirect) | View |
| 2023-06-15 Conversion | 2023-06-16 5:38 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,428,885 (Direct) | View |
| 2023-06-15 Gift | 2023-06-16 5:38 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,428,885 (Direct) | View |
| 2023-06-07 Exercise | 2023-06-09 5:12 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,438,885 (Direct) | View |
| 2023-06-07 Exercise | 2023-06-09 5:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,438,885 (Direct) | View |
| 2023-05-15 Tax Withholding | 2023-05-17 6:16 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 11,661 | $5.6 | 941,564 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 6:44 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 30,174,484 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 6:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 30,174,484 (Direct) | View |
| 2023-01-05 Conversion | 2023-05-05 6:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 35,338 | $0 | 30,174,484 (Direct) | View |
| 2023-01-05 Gift | 2023-05-05 6:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 19,000 | $0 | 30,174,484 (Direct) | View |
| 2022-04-25 Conversion(A) | 2023-04-28 4:32 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 75,500 | $0 | 73,549,979 (Direct) | View |
| 2022-04-25 Gift(A) | 2023-04-28 4:32 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 57,000 | $0 | 73,549,979 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 5:30 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,584,055 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 5:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,584,055 (Direct) | View |
| 2023-04-05 Gift | 2023-04-07 5:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,584,055 (Direct) | View |
| 2023-03-13 Conversion | 2023-03-15 7:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 3,000 | $0 | 10,647,382 (Direct) | View |
| 2023-03-13 Gift | 2023-03-15 7:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 3,000 | $0 | 10,647,382 (Direct) | View |
| 2023-03-08 Exercise | 2023-03-10 5:34 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 93,750 | $0 | 10,650,382 (Direct) | View |
| 2023-03-08 Exercise | 2023-03-10 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 93,750 | $2.48 | 10,650,382 (Direct) | View |
| 2023-03-08 Conversion | 2023-03-10 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,650,382 (Indirect) | View |
| 2023-03-08 Gift | 2023-03-10 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,650,382 (Direct) | View |
| 2023-03-02 Conversion | 2023-03-06 6:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 10,771,272 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 5:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 1,346 | $8.44 | 940,927 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:11 pm | N/A 2033-02-01 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 1,231,450 | $0 | 10,793,618 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-03 5:11 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 1,382 | $8.55 | 10,793,618 (Direct) | View |
| 2023-02-02 Conversion | 2023-02-03 5:11 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 10,793,618 (Direct) | View |
| 2023-01-05 Conversion | 2023-01-06 6:28 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 9,584,550 (Direct) | View |
| 2022-04-25 Gift | 2023-01-06 6:28 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 57,000 | $0 | 9,584,550 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 6:17 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,662,550 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 6:17 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,662,550 (Direct) | View |
| 2022-12-01 Conversion | 2022-12-02 6:17 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 9,662,550 (Direct) | View |
| 2022-11-15 Tax Withholding | 2022-11-17 6:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,751 | $11.86 | 570,265 (Direct) | View |
| 2022-11-03 Exercise | 2022-11-04 6:39 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,708,011 (Direct) | View |
| 2022-11-03 Exercise | 2022-11-04 6:39 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,708,011 (Direct) | View |
| 2022-11-03 Conversion | 2022-11-04 6:39 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 9,708,011 (Direct) | View |
| 2022-10-06 Exercise | 2022-10-07 7:19 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,747,204 (Direct) | View |
| 2022-10-06 Exercise | 2022-10-07 7:19 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,747,204 (Direct) | View |
| 2022-10-06 Conversion | 2022-10-07 7:19 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 9,747,204 (Direct) | View |
| 2022-09-01 Exercise | 2022-09-02 7:24 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,785,757 (Direct) | View |
| 2022-09-01 Exercise | 2022-09-02 7:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,785,757 (Direct) | View |
| 2022-09-01 Conversion | 2022-09-02 7:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 9,785,757 (Direct) | View |
| 2022-08-15 Tax Withholding | 2022-08-17 6:32 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,751 | $12.96 | 536,078 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-05 7:34 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,843,210 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-05 7:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,843,210 (Direct) | View |
| 2022-08-04 Conversion | 2022-08-05 7:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 9,843,210 (Direct) | View |
| 2022-07-07 Exercise | 2022-07-08 6:36 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,882,535 (Direct) | View |
| 2022-07-07 Exercise | 2022-07-08 6:36 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,882,535 (Direct) | View |
| 2022-07-07 Conversion | 2022-07-08 6:36 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 9,882,535 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 8:54 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,909,513 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 8:54 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,909,513 (Direct) | View |
| 2022-06-02 Conversion | 2022-06-06 8:54 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,000 | $0 | 9,909,513 (Direct) | View |